Studies suggest blockbuster GLP-1 drugs can treat alcohol addiction In November 2024, a study published in JAMA Psychiatry made the headlines as it suggested that the blockbuster drugs Ozempic and Wegovy could potentially be repurposed to help people with alcohol use disorder
Candido R, Gaiotti S, Giudici F, Toffoli B, De Luca F, Velardi V, Petrucco A, Gottardi C, Manca E, Buda I, Fabris B, Bernardi S (2023) Real-world retrospective study into the effects of oral semaglutide (as a switchover or add-on therapy) in type 2 diabetes
The Atkins brand was doing low-carb long before it was trendy
Joshua Poole Industry news Industry news Category news Category news Reports Key trends Multimedia Journal Events Suppliers Home Industry news Industry news Category news Category news Reports Key trends Multimedia Events Suppliers IFT FIRST 2026 review: GLP-1 ripple effect reshapes functional food innovation Joshua Poole Key takeaways GLP-1 use accelerates wider demand for satiety, nutrient density, sustained energy, and digestive support
M., Alasmari, R